Literature DB >> 30930034

Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial.

Henry W Mahncke1, Sarah-Jane Kim2, Annika Rose2, Catherine Stasio2, Peter Buckley3, Stanley Caroff4, Erica Duncan5, Sarah Yasmin6, L Fredrik Jarskog7, J Steven Lamberti8, Keith Nuechterlein9, Martin Strassnig10, Dawn Velligan11, Joseph Ventura9, Trina Walker12, T Scott Stroup13, Richard S E Keefe12.   

Abstract

OBJECTIVE: Cognitive impairment in schizophrenia is a core feature of the disorder. Computerized cognitive training has shown promise in pilot studies. A 26-week randomized blinded placebo-controlled trial was conducted to investigate the effect of a novel computerized cognitive training program on cognitive and functional capacity outcomes.
METHOD: The study followed MATRICS guidelines for the evaluation of interventions designed to improve cognitive function in schizophrenia. Participants (N = 150) were randomized to experimental (computerized cognitive training in a game-like format) or active control (computer games) groups. Training was conducted in-clinic, with an intended training schedule of 5 days per week, 1 h per day, for 26 weeks. Co-primary outcome measures were the MATRICS Consensus Cognitive Battery (MCCB) composite score and the UCSD Performance-Based Skills Assessment (UPSA-2) total score, secondary outcome measures included the Cognitive Assessment Interview (CAI) and the Short-Form-12 Mental Composite Score (SF-12 MCS). Target engagement was assessed with task-learning based assessment.
RESULTS: At baseline, the groups were well matched. No significant effect of the experimental treatment was seen on the primary or secondary outcome measures compared to the active control. Review of the task learning/target engagement data suggested inadequate target engagement.
CONCLUSIONS: Results do not support a cognitive or functional capacity benefit from this implementation of a computerized cognitive training program in people with schizophrenia. In future trials, careful consideration is merited of the assessment of task learning/target engagement, the effects of making the cognitive training game-like on motivation, and the implicit effects of trial requirements on participant selection.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30930034      PMCID: PMC6544484          DOI: 10.1016/j.schres.2019.03.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  42 in total

1.  Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.

Authors:  Christopher R Bowie; Susan R McGurk; Brent Mausbach; Thomas L Patterson; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2012-07       Impact factor: 18.112

2.  Concealment and fabrication by experienced research subjects.

Authors:  Eric G Devine; Megan E Waters; Megan Putnam; Caitlin Surprise; Katie O'Malley; Courtney Richambault; Rachel L Fishman; Clifford M Knapp; Elissa H Patterson; Ofra Sarid-Segal; Chris Streeter; Laurie Colanari; Domenic A Ciraulo
Journal:  Clin Trials       Date:  2013-07-18       Impact factor: 2.486

3.  The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?

Authors:  Robert W Buchanan; Richard S E Keefe; Daniel Umbricht; Michael F Green; Thomas Laughren; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-04-21       Impact factor: 9.306

4.  A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Authors:  Donald C Goff; J Steven Lamberti; Andrew C Leon; Michael F Green; Alexander L Miller; Jayendra Patel; Theo Manschreck; Oliver Freudenreich; Steven A Johnson
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

5.  Engagement with the auditory processing system during targeted auditory cognitive training mediates changes in cognitive outcomes in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Torsten B Neilands; Rachel Loewy; Sophia Vinogradov
Journal:  Neuropsychology       Date:  2016-09-12       Impact factor: 3.295

6.  Effects of age and cognitive reserve on cognitive remediation therapy outcome in patients with schizophrenia.

Authors:  Dimitris Kontis; Vyv Huddy; Clare Reeder; Sabine Landau; Til Wykes
Journal:  Am J Geriatr Psychiatry       Date:  2013-03       Impact factor: 4.105

7.  Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation.

Authors:  Jean-Pierre Lindenmayer; Susan R McGurk; Anzalee Khan; Saurabh Kaushik; Amod Thanju; Lisa Hoffman; Gladys Valdez; Deborah Wance; Edith Herrmann
Journal:  Schizophr Bull       Date:  2012-11-03       Impact factor: 9.306

Review 8.  Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.

Authors:  David J McCann; Nancy M Petry; Anders Bresell; Eva Isacsson; Ellis Wilson; Robert C Alexander
Journal:  J Clin Psychopharmacol       Date:  2015-10       Impact factor: 3.153

9.  Computerized cognitive remediation training for schizophrenia: an open label, multi-site, multinational methodology study.

Authors:  N V Murthy; H Mahncke; B E Wexler; P Maruff; A Inamdar; M Zucchetto; J Lund; S Shabbir; S Shergill; M Keshavan; S Kapur; M Laruelle; R Alexander
Journal:  Schizophr Res       Date:  2012-02-18       Impact factor: 4.939

10.  Differential effect of motivational features on training improvements in school-based cognitive training.

Authors:  Benjamin Katz; Susanne Jaeggi; Martin Buschkuehl; Alyse Stegman; Priti Shah
Journal:  Front Hum Neurosci       Date:  2014-04-24       Impact factor: 3.169

View more
  4 in total

1.  Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial.

Authors:  Eric J Lenze; Angela Stevens; Jill D Waring; Vy T Pham; Rita Haddad; Josh Shimony; J Philip Miller; Christopher R Bowie
Journal:  Am J Psychiatry       Date:  2020-03-26       Impact factor: 18.112

Review 2.  Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.

Authors:  Jacqueline Lutz; Emanuela Offidani; Laura Taraboanta; Shaheen E Lakhan; Timothy R Campellone
Journal:  Front Digit Health       Date:  2022-08-18

3.  Artificial Cognitive Systems Applied in Executive Function Stimulation and Rehabilitation Programs: A Systematic Review.

Authors:  Luis F Castillo-Ossa; Juan M Corchado; Carolina Robledo-Castro
Journal:  Arab J Sci Eng       Date:  2022-09-28       Impact factor: 2.807

4.  Feasibility and tolerability of a cognitive remediation clinical service in first episode coordinated specialty care.

Authors:  Kathryn E Lewandowski
Journal:  Early Interv Psychiatry       Date:  2020-06-08       Impact factor: 2.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.